Login
$KALA
$3.77 -$0.06 (1.56%) After hours

$KALA 8-K/A SEC Filings

Filed On Filing
02 Oct 2025 8-K/A: Costs Associated with Exit or Disposal Activities; Departure/Election of Directors or Officers; Compensation

1167 Massachusetts Ave., Arlington, MA 02476 · Tel 781.996.5252 · Fax 781.642.0399 · www.kalarx.com

12 Jul 2022 8-K/A: Financial Statements and Exhibits

On July 8, 2022 (the “Closing Date”), Kala Pharmaceuticals, Inc. (“Kala”, the “Company” “we” or “us”) completed the previously announced transaction (the “Transaction”), pursuant to which, Alcon Pharmaceuticals Ltd. and Alcon Vision, LLC...

28 Jan 2022 8-K/A: Financial Statements and Exhibits

As of September 30, 2021 and for the Nine Months Then Ended, and

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support